Your email has been successfully added to our mailing list.

×
0.000686922060766224 0.000686922060766224 0.0039630118890357 -0.000528401585204697 0.0180977542932629 0.0417437252311757 0.0488771466314399 0.0317040951122854
Stock impact report

AcelRx's DSUVIA Was Just Approved And The Stock Is Primed For A Sharp Upward Move [Seeking Alpha]

AcelRx Pharmaceuticals, Inc. (ACRX) 
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am Check Earnings Report
US:NASDAQ Investor Relations: ir.acelrx.com/investor-relations
Company Research Source: Seeking Alpha
AcelRx's DSUVIA Was Just Approved And The Stock Is Primed For A Sharp Upward MoveSummaryLast Friday, November 2, 2018, AcelRx Pharmaceuticals announced the FDA’s approval of its lead drug, DSUVIA, for use in the United States.This recent regulatory approval has eliminated nearly all near-term investment risk in the company and the stock could be set for sharp moves upward.A Licensing Agreement with a European partner to commercialize the product in the EU would provide the capital necessary to exploit the massive U.S. market opportunity for DSUVIA. Show less Read more
Impact Snapshot
Event Time:
ACRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ACRX alerts
Opt-in for
ACRX alerts

from News Quantified
Opt-in for
ACRX alerts

from News Quantified